期刊文献+

细胞周期G1调节因子在尖锐湿疣皮损中的表达 被引量:2

Expression of Cell Cycle Related Factors Cyclin D1,CDK4,P16^(MTS1) and PRb in Condyloma Acuminatum
原文传递
导出
摘要 目的探讨细胞周期G1调控点(checkpoint)相关调节因子细胞周期素D1(CyclinD1)、周期素依赖性蛋白激酶4(CDK4)、多重肿瘤抑制因子(P16MTS1)及视网膜母细胞瘤蛋白(PRb)在HPV6/11相关尖锐湿疣(CA)皮损中的表达和意义。方法采用SP免疫组化染色技术检测27例经PCR检测含HPV6/11DNA的CA皮损和10例正常人皮肤(包皮)中CyclinD1、CDK4、P16MTS1及PRb的表达和分布。结果①正常人皮肤及CA皮损均无CyclinD1表达。②CA皮损基底细胞表达CDK4(均数2.19)较正常人皮肤(均数4.8)降低(P<0.01)。③CA皮损棘细胞表达P16MTS1(均数1.33)较正常人皮肤(均数0)增强(P<0.05)。④CA皮损基底细胞和棘细胞表达PRb(均数各为0.89、0.44)较正常人皮肤(均数均为0)均增强(P<0.05)。结论HPV6/11CA相关皮损的细胞周期G1调控点无明显异常,可能是这类CA皮损不易恶变的原因之一。 Objective To investigate the expression and im plication of cell-cycle related factors(Cyclin D1,CDK4,P16 MTS1 and PRb)in condyloma acuminatum(CA).Methods The expression and distribution of cyclin D1,CDK4,P16 MTS1 and PRb were detected by immunohisto chemical technique streptavidin peroxidase(SP)in 27cases of HPV6/11positive CA that were confirmed by PCR and 10cases of norm al skins(foreskins).Results①Cyclin D1was not expressed in both normal skin and lesions of CA.②The intensity of expression of CDK4was 2.19in the basal cells in the lesions of CA,which was significantly weaker than that in normal skin(4.8,P<0.01).③The intensity of expression of P16 MTS1 was 1.33in prickle cells in the lesio ns of CA,which was significantly str onger than that in normal skin(0,P<0.05).④The intensity of expression of PRb in both basal and prickle cells of CA were 0.89and 0.44,respectively,which were significantly stronger than those in normal skin(0and 0,P<0.05).Conclusion There is no significant alteration i n G1check point of cell cycle in the le sions of CArelated to HPV6/11.[
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2002年第4期287-289,共3页 Chinese Journal of Dermatology
关键词 尖锐湿疣 细胞周期蛋白D1 细胞周期蛋白质依赖激酶类 蛋白质P16 视网膜母细胞瘤蛋白 皮肤损害 Condylomata acuminata Cyclin D1 Cyclin-dependent kinases Protein p16 Retinoblas-toma protein
  • 相关文献

参考文献9

  • 1MateJL,ArizaA,RocaX,etal.ExpressionpatternsofcyclinsD1andEincondylomaacuminatumincomparisonwithpsoriaticproli-ferativelesions[].The Journal of Pathology.1998
  • 2MarxJ.Howcellscycletowardscancer[].Science.1994
  • 3JonesDL,MungerK.Analysisofthep53-mediatedG1growtharrestpathwayincellsexpressingthehumanpapillomavirustype16E7oncoprotein[].Journal of Virology.1997
  • 4GageJR,MeyersC,WettsteinFO.TheE7proteinsofthenonoco-genichumanpapillomavirustype6b(HPV-6b),andoftheonco-genicHPV-16differinretinoblastomaproteinbindingandotherproperties[].Journal of Virology.1990
  • 5BerezutskayaE,BagchiC.ThehumanpapillomavirusE7oncoproteinfunctionallyinteractswithS4subunitofthe26Sproteasome[].Journal of Biochemistry.1997
  • 6ShiozamaT,NikaidoT,ShimizuM,etal.ImmunohistochemicalanalysisoftheexpressionofCDK4andp16INK4inhumanen-dometrioid-typeendometrialcarcinoma[].Cancer.1997
  • 7MartinLG,DemersGW,GallowayDA.DisruptionoftheG1/Stransitioninhumanpapillomavirustype16E7-expressinghumancellsinassociatedwithalteredregulationofcyclinE[].Journal of Virology.1998
  • 8KrajewskaM,KrajewskiS,EpsteinJI,etal.Immunohistochemicalanalysisofbcl-2,bax,bcl-Xl,andmcl-1expressioninprostatecancers[].American Journal of Pathology.1996
  • 9YeagerT,StadlerW,BelairC,etal.Increasedp16levelscorrelatewithpRbalterationinhumanurothelialcells[].Cancer Research.1995

同被引文献11

  • 1杨崇札.再生障碍性贫缸[M].2版.天津:天津科技翻译出版公司,2000:14.
  • 2Krajewska M, Krajewski S, Epstein Jl, et al. Imnmnohistoehemical analysis of bcl-X,and mel-I expression in prostate cancers[ J]. Am J Pathol, 148 ( 5 ) : 1567-1576.
  • 3Borgstrom P, Hillan K, Sriramarao P, et al. Complete inhibition ofan-giogenesis and growth of microtumors by anti-vascularendothelial growth factor neutralizing antibody[ J ]. Cancer Res, 1996,56 (17) :
  • 4Potgens AGJ, Westphal GR, Dewaal RMW, et al. The role of vascular pemleability factor and fibroblast growth factor in tumor[ J]. Angiogencsis Biol Chcm Hoppc-scyler, 1995,376 ( 1 ) :57-60 .
  • 5Goto F, Goto K, Weindel K,et al. Synergistic effects of vascular: en- dothelial growth factor and basic fibroblast grovwth factor on the prolife ration and cordl for marion of bovine capillary endothelial c.ells within collagen gels [J]. Lab Invest, 1993,69 ( 5 ) : 508-517.
  • 6Krajewska M,Krajewski S,Epstein JI,et al.Immunohistochemical analysis of bcl-2,bax,bcl-X,and mcl-l expression in prostate cancers.Am J Pathol,1996,148:1567-1576.
  • 7Brown LF,Harrist TJ,Yeo KT,et al.Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid,dermatitis herpetiformis,and erythema multiforme.J Invest Dermatol,1995,104:744-749.
  • 8Brown LF,Olbricht SM,Berse B,et al.Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.J Immunol,1995,154:2801-2807.
  • 9Bhushan M,McLaughlin B,Weiss JB,et al.Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis.Br J Dermatol,1999,141:1054-1060.
  • 10Arbiser JL,Byers HR,Cohen C,et al.Altered basic fibroblast growth factor expression in common epidermal neoplasms:examination with in situ hybridization and immunohistochemistry.J Am Acad Dermatol,2000,42:973-977.

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部